Chiron, Corp.
Chiron, Corp., a leading player in the biotechnology sector, is headquartered in the United States and operates extensively across North America and Europe. Founded in the early 2000s, the company has achieved significant milestones, including advancements in therapeutic solutions and innovative drug development.
Chiron, Corp. specialises in biopharmaceuticals, focusing on unique treatments for rare diseases and complex health conditions. Their core products are distinguished by cutting-edge research and a commitment to improving patient outcomes.
With a strong market position, Chiron, Corp. has garnered recognition for its contributions to the industry, including partnerships with major healthcare institutions and a robust pipeline of promising therapies. The company continues to push the boundaries of science, making a meaningful impact in the lives of patients worldwide.
+62 vs industry average
Chiron, Corp.’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Chiron, Corp.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Chiron, Corp. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Chiron, Corp.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Chiron, Corp. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Novartis AG
Carbon Disclosure Project
Inherited from Novartis AGThe Climate Pledge
Inherited from Novartis AGUN Global Compact Climate Champions initiative
RE 100
Inherited from Novartis AGClimate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project